Fund Holdings — Exome Asset Management LLC

Total Portfolio Value:
$162.10M
Total Bought:
$36.26M
Total Sold:
$55.93M
Net Transaction:
-$19.67M
Notable People:
Alex R Forschner
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Guardant Health, Inc.(GH)82,73667,500-15,236$7.64M$10.13M6.25%+$2.48M
Praxis Precision Medicines, Inc.(PRAX)45,46927,205-18,264$14.65M$9.11M5.62%-$5.54M
TG Therapeutics, Inc.(TGTX)0164,915+164,915$0$9.06M5.59%+$9.06M
Cogent Biosciences, Inc.(COGT)278,533210,523-68,010$10.72M$8.15M5.03%-$2.57M
Ionis Pharmaceuticals, Inc.(IONS)110,06488,177-21,887$8.26M$6.99M4.31%-$1.27M
Eli Lilly and Company(LLY)7,0125,492-1,520$6.45M$6.59M4.06%+$137.8K
ABIVAX Société Anonyme(ABVX)046,878+46,878$0$6.25M3.85%+$6.25M
ALUMIS INC279,176204,418-74,758$6.15M$5.75M3.55%-$397.9K
Cytokinetics, Incorporated(CYTK)103,71860,056-43,662$6.84M$5.12M3.16%-$1.72M
ENLIVEN THERAPEUTICS INC220,091100,203-119,888$8.63M$5.09M3.14%-$3.54M
Vera Therapeutics, Inc.(VERA)114,99197,276-17,715$4.63M$4.17M2.57%-$452.0K
UnitedHealth Group Incorporated(UNH)12,8629,612-3,250$3.48M$4.00M2.46%+$514.7K
10x Genomics, Inc.(TXG)154,194102,629-51,565$3.27M$3.93M2.43%+$661.3K
Natera, Inc.(NTRA)18,65013,800-4,850$3.73M$3.75M2.31%+$16.2K
uniQure N.V.(QURE)081,056+81,056$0$3.73M2.30%+$3.73M
Rhythm Pharmaceuticals, Inc.(RYTM)40,58132,209-8,372$3.53M$3.58M2.21%+$46.8K
Maze Therapeutics, Inc.(MAZE)88,510114,692+26,182$2.64M$3.42M2.11%+$780.4K
Monte Rosa Therapeutics, Inc.(GLUE)179,484137,115-42,369$2.95M$3.32M2.05%+$365.7K
MoonLake Immunotherapeutics(MLTX)215,376166,493-48,883$4.01M$3.24M2.00%-$773.0K
Alkermes plc(ALKS)84,10361,336-22,767$2.97M$3.21M1.98%+$239.8K
Liquidia Corporation(LQDA)45,79639,224-6,572$1.73M$3.13M1.93%+$1.40M
United Therapeutics Corporation(UTHR)7,0535,410-1,643$4.18M$2.93M1.81%-$1.25M
Glaukos Corporation(GKOS)20,87419,862-1,012$2.25M$2.78M1.71%+$528.6K
Arrowhead Pharmaceuticals, Inc.(ARWR)45,72132,214-13,507$2.87M$2.63M1.62%-$240.9K
Agios Pharmaceuticals, Inc.(AGIO)125,06070,500-54,560$4.23M$2.62M1.61%-$1.61M
CRESCENT BIOPHARMA INC.153,191127,769-25,422$2.81M$2.30M1.42%-$514.3K
AstraZeneca PLC(AZN)012,045+12,045$0$2.25M1.39%+$2.25M
Boston Scientific Corporation(BSX)48,34748,3470$3.03M$2.06M1.27%-$970.3K
ADAGENE INC736,845488,293-248,552$2.89M$2.05M1.27%-$837.6K
Penumbra, Inc.(PEN)6,3006,3000$2.07M$1.99M1.23%-$79.5K
INTUITIVE SURGICAL INC6,3584,908-1,450$2.93M$1.95M1.20%-$979.2K
Viking Therapeutics, Inc.(VKTX)047,861+47,861$0$1.87M1.15%+$1.87M
Ocular Therapeutix, Inc.(OCUL)0181,588+181,588$0$1.78M1.10%+$1.78M
EQUILLIUM INC0552,956+552,956$0$1.77M1.09%+$1.77M
Ascendis Pharma A/S(ASND)06,573+6,573$0$1.75M1.08%+$1.75M
CORBUS PHARMACEUTICALS HLDGS234,136184,914-49,222$2.20M$1.73M1.07%-$464.0K
CYTOMX THERAPEUTICS INC.521,468460,067-61,401$2.45M$1.73M1.06%-$725.6K
VERASTEM INC636,700429,041-207,659$3.37M$1.64M1.01%-$1.74M
Nektar Therapeutics(NKTR)022,417+22,417$0$1.56M0.97%+$1.56M
CLEARPOINT NEURO INC083,636+83,636$0$1.49M0.92%+$1.49M
Insmed Incorporated(INSM)26,65113,873-12,778$4.36M$1.48M0.91%-$2.88M
Caris Life Sciences, Inc.(CAI)078,180+78,180$0$1.39M0.86%+$1.39M
BridgeBio Pharma, Inc.(BBIO)67,49218,359-49,133$5.01M$1.37M0.84%-$3.64M
Zenas BioPharma, Inc.(ZBIO)80,73052,443-28,287$1.58M$1.33M0.82%-$247.3K
NOVABRIDGE BIOSCIENCES576,960576,9600$1.42M$1.13M0.69%-$294.3K
Establishment Labs Holdings Inc.(ESTA)13,10013,1000$743.8K$1.12M0.69%+$380.3K
Relay Therapeutics, Inc.(RLAY)278,30247,531-230,771$2.77M$889.3K0.55%-$1.88M
GERON CORP0624,046+624,046$0$798.8K0.49%+$798.8K
BRIGHT MINDS BIOSCIENCES INC010,110+10,110$0$709.7K0.44%+$709.7K
COMPASS THERAPEUTICS INC0276,165+276,165$0$604.8K0.37%+$604.8K
Replimune Group, Inc.(REPL)040,361+40,361$0$446.8K0.28%+$446.8K
ARBUTUS BIOPHARMA CORP75,48450,166-25,318$339.7K$240.8K0.15%-$98.9K
4D MOLECULAR THERAPEUTICS IN130,5640-130,564$1.22M$0—-$1.22M
APELLIS PHARMACEUTICALS INC
COM
85,5170-85,517$3.44M$0—-$3.44M
AVALO THERAPEUTICS INC159,3410-159,341$2.38M$0—-$2.38M
Elevance Health, Inc.(ELV)14,6770-14,677$4.30M$0—-$4.30M
LIPOCINE INC NEW60,8610-60,861$486.3K$0—-$486.3K
NEXTCURE INC115,5000-115,500$1.22M$0—-$1.22M
PALISADE BIO INC600,0000-600,000$1.05M$0—-$1.05M
SOLENO THERAPEUTICS INC61,6730-61,673$2.06M$0—-$2.06M
Page 1 of 1
Exome Asset Management LLC — 13F Holdings — Q2 2026 | TickerTrail